Sunaya Krishnapura, MD
@sunayak.bsky.social
Pediatrics Resident at Stanford
Vanderbilt University School of Medicine Class of 2025
UC Berkeley Class of 2020
Views my own
Vanderbilt University School of Medicine Class of 2025
UC Berkeley Class of 2020
Views my own
Reposted by Sunaya Krishnapura, MD
“There is a surprising lack of data comparing buprenorphine—the most common treatment for opioid use disorder—with no treatment. We found that the benefits of treatment were profound, substantially reducing risk of preterm birth and severe maternal morbidity.” - @stephenwpatrick.bsky.social
Study: Treating Opioid Use Disorder in Pregnancy with Buprenorphine Improves Maternal, Infant Health | Rollins School of Public Health | Emory University | Atlanta GA
A new study found that pregnant women with opioid use disorder who received buprenorphine treatment had lower rates of adverse outcomes compared to those who did not receive treatment.
sph.emory.edu
April 29, 2025 at 2:22 PM
“There is a surprising lack of data comparing buprenorphine—the most common treatment for opioid use disorder—with no treatment. We found that the benefits of treatment were profound, substantially reducing risk of preterm birth and severe maternal morbidity.” - @stephenwpatrick.bsky.social
At least 50% of pregnant women with opioid use disorder nationwide do not receive treatment
Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants
Full paper: ja.ma/3EyF00J
www.healio.com/news/pediatr...
Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants
Full paper: ja.ma/3EyF00J
www.healio.com/news/pediatr...
Buprenorphine during pregnancy improves outcomes for mothers, babies
HONOLULU — Buprenorphine treatment during pregnancy improved perinatal outcomes for women with opioid use disorder and their babies, compared with no treatment, according to a new study.The numb...
www.healio.com
April 28, 2025 at 9:50 AM
At least 50% of pregnant women with opioid use disorder nationwide do not receive treatment
Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants
Full paper: ja.ma/3EyF00J
www.healio.com/news/pediatr...
Our study in JAMA Health Forum found that buprenorphine treatment was associated with significant improvements in outcomes for mothers and infants
Full paper: ja.ma/3EyF00J
www.healio.com/news/pediatr...
Reposted by Sunaya Krishnapura, MD
From JAMA Health Forum: Buprenorphine treatment during pregnancy for opioid use disorder was associated with significantly improved maternal and infant outcomes compared to no treatment. #PAS2025
https://ja.ma/3EyF00J
https://ja.ma/3EyF00J
April 27, 2025 at 9:00 PM
From JAMA Health Forum: Buprenorphine treatment during pregnancy for opioid use disorder was associated with significantly improved maternal and infant outcomes compared to no treatment. #PAS2025
https://ja.ma/3EyF00J
https://ja.ma/3EyF00J
Reposted by Sunaya Krishnapura, MD
Pregnant women with opioid use disorder face huge barriers to treatment.
Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications.
Treatment saves lives & we found ~5 percentage point reduction in preterm birth.
Study ➔ sph.emory.edu/news/news-re...
Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications.
Treatment saves lives & we found ~5 percentage point reduction in preterm birth.
Study ➔ sph.emory.edu/news/news-re...
Study: Treating Opioid Use Disorder in Pregnancy with Buprenorphine Improves Maternal, Infant Health | Rollins School of Public Health | Emory University | Atlanta GA
A new study found that pregnant women with opioid use disorder who received buprenorphine treatment had lower rates of adverse outcomes compared to those who did not receive treatment.
sph.emory.edu
April 27, 2025 at 11:59 PM
Pregnant women with opioid use disorder face huge barriers to treatment.
Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications.
Treatment saves lives & we found ~5 percentage point reduction in preterm birth.
Study ➔ sph.emory.edu/news/news-re...
Our new study: Buprenorphine = fewer preterm births, fewer severe maternal complications.
Treatment saves lives & we found ~5 percentage point reduction in preterm birth.
Study ➔ sph.emory.edu/news/news-re...
Reposted by Sunaya Krishnapura, MD
Piece in @thenewrepublic.bsky.social cites our team's research, led by graduating Vanderbilt medical student Sunaya Krishnapura.
Striking beginning to this article ...
newrepublic.com/article/1935...
Striking beginning to this article ...
newrepublic.com/article/1935...
Iowa Republicans Want to Shield Pesticide Firms From Cancer Lawsuits
A bill threading its way through the state legislature would make it almost impossible to sue pesticide companies for health complications caused by their products.
newrepublic.com
April 18, 2025 at 12:13 PM
Piece in @thenewrepublic.bsky.social cites our team's research, led by graduating Vanderbilt medical student Sunaya Krishnapura.
Striking beginning to this article ...
newrepublic.com/article/1935...
Striking beginning to this article ...
newrepublic.com/article/1935...